Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 408 participants.

Also called NCT03847883

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 408 participants (enrolled count) (from the registry)
Sponsor
Department of Medical Services Ministry of Public Health of Thailand (from the registry)
Registry
  • NCT NCT03847883
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Thailand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03847883. Randomized; triple masking; primary purpose treatment. Start 2011-01-01 (actual); primary completion 2018-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study
Condition
Acute Stroke
Intervention (Drug)
Intravenous Solution Ateplase
Lead sponsor
Department of Medical Services Ministry of Public Health of Thailand (class: other government)
Collaborator
Lumpang Hospital (class: not stated)

Record details

Record id
cardio:ct-nct03847883
Content hash
081c8eeafa71c68d3f12920bd189385009074f49cad31ac507f046f86f73c909